Breast Cancer Research

official impact factor 5.79

Email this article to a friend

Has tamoxifen had its day?

Michael Baum

Breast Cancer Res 2002, 4:213-217 doi:10.1186/bcr536


For a reply to this article, please see http://breast-cancer-research.com/inpress/bcr538

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.